Sign in
  Edit search
Analysis of 3-year national reimbursement application data o…
Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis.
Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis.
Article, Chapter
Authors: R.J.B. Driessen
Publication: British Journal of Dermatology, Volume:159, Issue:3, Page(s):760-761
Published: John Wiley and Sons, Ltd, 2008
ISSN: 0007-0963
  Full text availability for this item
View Full Text Source:British Journal of Dermatology,British Journal of Dermatology,Wiley Online Library: Complete Journals Opens in new Window
Journal:  British Journal of Dermatology Source:Wiley Online Library: Complete Journals Opens in new Window
Collection:  Wiley Online Library: Complete Journals Opens in new Window
Coverage:
  • 1892-02-01~2022-12-01; volume:4;issue:2~volume:187;issue:6
View Full Text Source:British Journal of Dermatology,British Journal of Dermatology,Wiley Online Library Database Model 2021 Opens in new Window
Journal:  British Journal of Dermatology Source:Wiley Online Library Database Model 2021 Opens in new Window
Collection:  Wiley Online Library Database Model 2021 Opens in new Window
Coverage:
  • 1997~present; volume:136~present;issue:1~present
Full Text Available
Journal:  British journal of dermatology : improving patient outcomes in skin disease worldwide / Source:Oxford University Press Journals (UKB 2021-2023) Opens in new Window
Collection:  Oxford University Press Journals (UKB 2021-2023)
Coverage:
  • 1996~present; volume:34~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item